Loading [Contrib]/a11y/accessibility-menu.js
JEFC
  • Menu
  • Articles
    • Editorial
    • Opinion and Commentary
    • Original article
    • Review
    • Technical note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • IPEC Foundation
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jefc.scholasticahq.com/feed
×
Editorial
Vol. 9, Issue 1, 2018March 24, 2018 CDT

PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.

shireesh apte,
hyaluronidase pegph20 rhuph20 functional excipient bioactive excipient
JEFC
apte, shireesh. 2018. “PEGylated Recombinant Human Hyaluronidase (PEGPH20): Transition from a Novel Functional Excipient to an API to Increase the Chemotherapeutic Effectiveness against Hyaluronan-Rich Cancers.” Journal of Excipients and Food Chemicals 9 (1).
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)

View more stats

Powered by Scholastica, the modern academic journal management system